1-6 of 6
Eliana C M Miranda, MEd
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Results With Dasatinib Or Nilotinib In Third Line Therapy Of Chronic Myeloid Leukemia After Failure Of Two Tyrosine Kinase Inhibitors

Free
Beatriz F Ribeiro, Eliana C M Miranda, MEd, Marcia T Delamain, MD, Gislaine Borba Oliveira, MD,, Maria Helena Almeida, RN, Vagner O Duarte, Irene L Metze, MD, PhD, Carmino A De Souza, Sr., MD, PhD, Rosana A Silveira, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5189.
https://doi.org/10.1182/blood.V122.21.5189.5189
Published: 2013
Journal Articles

Evaluation Of hOCT1expression In Patients With Chronic Myeloid Leukemia (CML) Treated With Imatinib In First Line

Free
Cintia Do Couto Mascarenhas, PhD, Maria Helena Almeida, PhD, Eliana C M Miranda, MEd, Bruna Virgilio, Marcia Torresan Delamain, MD, Gislaine O. Duarte, PhD, Vagner O Duarte, Carmino A De Souza, Sr., MD, PhD, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4041.
https://doi.org/10.1182/blood.V122.21.4041.4041
Published: 2013
Journal Articles

Lack Of Advantage Of Peripheral Blood Hematopoietic Stem Cell Transplantation Over Bone Marrow From HLA Matched Related Donors After Myeloablative Conditioning For Hematologic Malignancies

Free
Paulo Vidal Campregher, MD, Nelson Hamerschlak, MD, PhD, Vergilio Antonio Renzi Colturato, MD, Marcos Mauad, MD, Mair Pedro de Souza, MD, Luis Fernando S Bouzas, MD, PhD, Rita deCássia Barbosa Tavares, MD, Jose C. Barros, MD, Ricardo Chiattone, MD, Lisandra della Costa, MD, Lucia Silla, MD, PhD, Afonso Celso Vigorito, MD, PhD, Eliana C M Miranda, MEd, Vaneuza Araujo Moreira, MD, Mary E.D. Flowers, MD
Journal: Blood
Blood (2013) 122 (21): 5470.
https://doi.org/10.1182/blood.V122.21.5470.5470
Published: 2013
Journal Articles

Predictive Value Of Early Molecular Responses In Outcomes Of Patients With Chronic Myeloid Leukemia Treated With Imatinib In First-Line Therapy

Free
Katia B. Pagnano, MD, PhD, Bruna Vergilio, Eliana C M Miranda, MEd, Marcia Torresan Delamain, MD, Maria Helena De Almeida, RN, Vagner O Duarte, Gislaine O. Duarte, PhD, Carmino A De Souza, Sr., MD, PhD, Irene Lorand-Metze, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4941.
https://doi.org/10.1182/blood.V122.21.4941.4941
Published: 2013
Journal Articles

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

Free
Beatriz F Ribeiro, Bruna Vergilio, Eliana C M Miranda, MEd, Maria Helena Almeida, RN, Marcia Torresan Delamain, MD, Rosana A Silveira, MSc, Carmino A De Souza, Sr., MD, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Irene Lorand-Metze, MD, PhD, Vagner O Duarte, Gislaine O. Duarte, PhD, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1326.
https://doi.org/10.1182/blood.V122.21.1326.1326
Published: 2013
Journal Articles

Metabolomic Model For Chronic Gvhd Diagnosis

Free
Marcos Rodrigo Alborghetti, Sr., PhD, Maria Elvira P Corrêa, DDS, PhD, Andreia Aparecida da Silva, DDS, PhD, Eliana C M Miranda, MEd, Carmino A De Souza, Sr., MD, PhD, Mauricio L Sforça, Sr., PhD, Ana Carolina de Mattos Zeri, PhD
Journal: Blood
Blood (2013) 122 (21): 3304.
https://doi.org/10.1182/blood.V122.21.3304.3304
Published: 2013